19 November 2017
News and Views
Links and Services
A population-based study reported in the latest British Journal of Cancer investigates proton pump inhibitors and risk of gastric cancer.
Proton pump inhibitor (PPI) use leads to hypergastrinaemia, which has been associated with gastro
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors